SB-334,867
SB-334867 is a drug that is used primarily in scientific research. It acts as a selective, non-peptide antagonist at the orexin receptor subtype OX1, with around 50x selectivity over subtype OX2.
Pharmacology[edit | edit source]
SB-334867 was the first non-peptide antagonist developed that is selective for the orexin receptor. The orexin system was initially identified as a central promoter of wakefulness, but has since been found to regulate a wide variety of behaviors. SB-334867 has been used in a variety of animal studies to explore the role of the orexin system in behavior.
Chemistry[edit | edit source]
SB-334867 is a phenyl piperazine derivative, with a trifluoromethyl group on the phenyl ring, and a urea group linking the piperazine ring to a naphthalene moiety.
Uses in research[edit | edit source]
SB-334867 has been used in a variety of research contexts to investigate the role of the orexin system in regulating a variety of behaviors. These include studies on feeding behavior, sleep-wake cycles, reward seeking, and drug addiction.
See also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD